UPDATE 1-Novo Nordisk CEO Lars Rebien Sorensen to step down by end-2016

COPENHAGEN, Sept 1 (Reuters) - Lars Rebien Sorensen, chief

executive of the world's largest insulin maker Novo Nordisk

, will step down by the end of 2016 after 16 years in

the job, the Danish company said on Thursday.

Read more